ORTHOCELL LIMITED — Director's Dealing 2020

Feb 10, 2020

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Orthocell Limited

ABN 57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Matthew Callahan
Date of appointment	10 February 2020

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

Part 2 – Director’s relevant interests in securities of which the director is not the

registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstancesgiving rise to the relevant interest.SRV Nominees Pty Ltd(Mr Callahan is a founder and directorof Stone Ridge Ventures Pty Ltd whichis the manager of the SRV Tech Trust,a venture capital fund. Mr Callahan isconsidered to have a relevant interest inthese shares due to his position as adirector or shareholder of the respectivetrusteecompaniesandholdsabeneficial interest in the SRV Trust. TheSRV Trust is the carry trust for the SRVTech Trust)

Number & class of Securities200,000 Ordinary Shares

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Shenasaby Investments Pty Ltd <For the Shenasaby A/C> 21,053 Ordinary Shares < Shenasaby Investment P/L A/C> 47,000 Ordinary Shares < Shenasaby Trust> 371,710 Ordinary Shares < Shenasaby Family Trust> 1,850,000 Unlisted Options exercisable at $0.395 expiring 8 May 2021 (vesting conditions set out in NOM for General Meeting held on 7 May 2018) <Shenasaby Super Fund A/C> 12,500 Ordinary Shares (Mr Callahan is a beneficiary of the trusts)

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
No. and class of securities towhich interest relates	N/A

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002